Represents the widest range of reversed phase selectivity available, with just 4 stationary phases: Aqueous C18, IBD, Biphenyl, and PFP Propyl.
Simplifies column choice for fast, effective method development.
Offers greater control to more easily resolve closely eluting peaks.
Maximizes column screening efficiency by ensuring orthogonality between analytical runs.
Fits universally on any HPLC or UHPLC instrumentation.
Selectivity is the most influential factor affecting peak separation, or resolution. Restek Ultra Selective Liquid Chromatography™ (USLC®) technology is the directed application of orthogonal selectivity to help the practicing chromatographer develop methods more efficiently and more effectively. The Restek USLC® column set offers the widest range of selectivity in the industry using just 4 unique stationary phases—Aqueous C18, IBD, Biphenyl, and PFP Propyl—to simplify phase selection.
Restek USLC® columns are available on two silica lines to accommodate any instrument platform or chromatographic application. Pinnacle® DB columns (1.9 µm) feature base deactivated silica and are recommended for scalable HPLC and UHPLC analyses. Ultra columns (3 and 5 µm) use highest purity silica and are well suited for traditional HPLC analyses.
‘Smelling’ Prostate Cancer A research team from the University of Liverpool and the University of the West of England (UWE Bristol) has reached an important milestone towards creating a urine diagnostic test for prostate cancer that could mean that invasive diagnostic procedures that men currently undergo eventually become a thing of the past.Charting Kidney Cancer Metabolism Changes in cell metabolism are increasingly recognized as an important way tumors develop and progress, yet these changes are hard to measure and interpret. A new tool designed by MSK scientists allows users to identify metabolic changes in kidney cancer tumors that may one day be targets for therapy.Portable Kit Can Recover Traces of Chemical Evidence A chemist at the National Institute of Standards and Technology (NIST) has developed a portable version of his method for recovering trace chemicals such as environmental pollutants and forensic evidence including secret graves and arson fire debris.Diagnosis of Two Rare Childhood Diseases Improved For the first time, researchers have developed tests that could improve the diagnosis of two rare childhood diseases known as congenital disorders of glycosylation (CDGs) and metachromatic leukodystrophy, and that could even lead to new treatments for CDGs. Artemisinin Mechanism Uncovered New understanding of how artemisinin works could facilitate development of new drugs and therapeutic strategies against malaria.Cleaning Out the Membrane Each Day Cell membranes are made up of a lipid bilayer that is constantly changing due to the flux of material in and out of the cell. AMRI Acquires Whitehouse Laboratories Strategically extends AMRI's analytical offerings in rapidly expanding area of outsourcing services.Novel Approach to Understanding Brain Function Russell Poldrack scanned his brain to create the most detailed map of brain connectivity ever. New Analysis Technique for Chiral Activity in Molecules Professor Hyunwoo Kim of the Chemistry Department and his research team have developed a technique that can easily analyze the optical activity of charged compounds by using nuclear magnetic resonance (NMR) spectroscopy. High Throughput Mass Spectrometry-Based Screening Assay Trends Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.